R1MD34 Stock Overview
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
ResMed Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$245.00 |
52 Week High | US$280.00 |
52 Week Low | US$183.79 |
Beta | 0.65 |
1 Month Change | 5.99% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -5.48% |
5 Year Change | n/a |
Change since IPO | 44.88% |
Recent News & Updates
Recent updates
Shareholder Returns
R1MD34 | BR Medical Equipment | BR Market | |
---|---|---|---|
7D | 1.2% | -0.6% | -1.6% |
1Y | n/a | 9.0% | 18.9% |
Return vs Industry: Insufficient data to determine how R1MD34 performed against the BR Medical Equipment industry.
Return vs Market: Insufficient data to determine how R1MD34 performed against the BR Market.
Price Volatility
R1MD34 volatility | |
---|---|
R1MD34 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 6.7% |
Market Average Movement | 4.7% |
10% most volatile stocks in BR Market | 7.9% |
10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: R1MD34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine R1MD34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | 10,140 | Mick Farrell | https://www.resmed.com |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
ResMed Inc. Fundamentals Summary
R1MD34 fundamental statistics | |
---|---|
Market cap | R$143.63b |
Earnings (TTM) | R$4.43b |
Revenue (TTM) | R$22.43b |
32.4x
P/E Ratio6.4x
P/S RatioIs R1MD34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
R1MD34 income statement (TTM) | |
---|---|
Revenue | US$4.50b |
Cost of Revenue | US$1.99b |
Gross Profit | US$2.52b |
Other Expenses | US$1.63b |
Earnings | US$890.39m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 6.06 |
Gross Margin | 55.86% |
Net Profit Margin | 19.77% |
Debt/Equity Ratio | 27.4% |
How did R1MD34 perform over the long term?
See historical performance and comparison